H31.129 Diffuse secondary atrophy of choroid, unspecified eye

Name of the Condition

• Diffuse secondary atrophy of choroid, unspecified eye (ICD Code: H31.129)

Summary

Diffuse secondary atrophy of the choroid, unspecified eye, is a condition characterized by widespread degeneration and thinning of the choroidal tissue in one eye, resulting from an underlying cause. This process can lead to structural changes in the choroid, potentially impacting retinal health and visual function depending on the extent and location of the atrophy.

Causes

Diffuse secondary atrophy of the choroid typically results from systemic diseases, chronic inflammation, or vascular insufficiency affecting ocular blood flow. Common underlying causes include hypertension, atherosclerosis, autoimmune disorders, or long-term exposure to certain environmental factors. In some cases, it may be associated with infections or neoplastic processes.

Risk Factors

• Advanced age
• Systemic vascular diseases (e.g., hypertension, atherosclerosis)
• Chronic ocular inflammation or infection
• Autoimmune disorders
• Prolonged exposure to ultraviolet light
• Genetic predispositions

Symptoms

• Gradual loss of peripheral or central vision in the affected eye
• Blurred or distorted vision in the affected eye
• Difficulty adapting to low light conditions in the affected eye
• Visual field defects in the affected eye
• Reduced visual acuity in advanced cases

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilated fundus evaluation, optical coherence tomography (OCT), and fluorescein angiography to assess choroidal structure and function. Clinical history and systemic evaluations may help identify underlying causes.

Treatment Options

Treatment focuses on addressing the underlying cause and managing symptoms. This may include controlling systemic conditions (e.g., hypertension), anti-inflammatory therapies, or nutritional support. Visual rehabilitation and low-vision aids may be recommended for symptomatic relief.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and extent of choroidal damage. Regular follow-up with an ophthalmologist is essential to monitor disease progression and adjust management as needed. Early intervention may help preserve remaining vision.

Complications

Potential complications include progressive vision loss, retinal degeneration, and increased risk of secondary ocular conditions (e.g., choroidal neovascularization). Severe cases may lead to irreversible visual impairment.

Lifestyle & Prevention

• Manage systemic conditions (e.g., blood pressure, diabetes)
• Protect eyes from excessive UV exposure
• Maintain a balanced diet rich in antioxidants
• Avoid smoking, which may exacerbate vascular issues
• Regular eye exams for early detection

When to Seek Professional Help

Seek prompt medical attention if you experience sudden vision changes, persistent blurriness, or new visual field defects. Early evaluation can help identify underlying causes and prevent further damage.

Tips for Medical Coders

Document the affected eye (unspecified) and any underlying conditions contributing to the atrophy. Ensure clinical documentation supports the diagnosis and specifies whether the atrophy is secondary to a systemic or ocular condition. Use H31.129 when the eye is not specified in the record.